Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00180
Species: Homo sapiens
Position : chr1:16499333-16519333
Year: 2021
Title: EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  33712565
MONDO: MONDO:0006120
Tissue: Breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF7
CVCL ID: CVCL_0031
Cell Type: breast carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR, Western blot
About Target Gene
Target gene : EPHA2
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_03479 chr1:16479332-16539780 Cervical Epithelium cervical adenocarcinoma cell cervical cancer
E_03480 chr1:16479332-16539780 Colon Epithelium colorectal carcinoma cell colorectal carcinoma
E_03481 chr1:16479332-16539780 Breast Epithelium breast carcinoma cell breast carcinoma
E_00179 chr1:16499333-16519333 Colon colorectal carcinoma cell colorectal cancer
E_00181 chr1:16499333-16519333 Cervical Epithelium cervical adenocarcinoma cell cervical cancer
Expression of Target Genes for the Enhancer